Image_1_Preoperative Three-Dimensional Lung Simulation Before Thoracoscopic Anatomical Segmentectomy for Lung Cancer: A Systematic Review and Meta-Analysis.TIF by Zhongtian Xiang (12324683)

“…The results of the meta-analysis showed that preoperative 3D lung simulation could significantly decrease the blood loss (mean difference [MD]: −16.21 [−24.95 to −7.47]ml, p = 0.0003), operative time (MD: −13.03 [−25.56 to −0.50]ml, p = 0.04), conversion rate (conversion from segmentectomy to thoracotomy or lobectomy) (MD: 0.12 [0.03–0.48], p = 0.003), postoperative hospital stay (MD: −0.25 [−0.46 to 0.04]days, p = 0.02) and total number of complications (MD: 0.59 [0.43–0.82], p = 0.001) compared with non-3D procedures. …”

Long-Term Neurobehavioral and Metabolic Outcomes in Offspring of Mothers with Diabetes During Pregnancy: A large, population-based cohort study in Ontario, Canada. by Denice S Feig (18546680)

“…</p><p dir="ltr">Research Design and Methods</p><p dir="ltr">We conducted a population-based, cohort study of deliveries in Ontario between April 1991, and March 2018. …”

DataSheet2_Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies.xlsx by Heng-Chang Hu (8122892)

“…Thus, we aimed to perform a systematic review and meta-analysis of animal studies to evaluate the antioxidant and anti-inflammatory properties of resveratrol when used in the treatment of diabetic nephropathy.…”

DataSheet1_Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies.PDF by Heng-Chang Hu (8122892)

“…Thus, we aimed to perform a systematic review and meta-analysis of animal studies to evaluate the antioxidant and anti-inflammatory properties of resveratrol when used in the treatment of diabetic nephropathy.…”

Supplementary Material for: Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study) by Distler M. (8332950)

“…<b><i>Results:</i></b> Sixteen patients were analyzed: 7 to omalizumab and 9 to placebo (mean age 47.7 ± 13.8 vs. 45.4 ± 8.8 years; 66.6 vs. 85.7% were female; mean disease duration 10.0 ± 5.1 vs. 4.5 ± 2.9 years, respectively). …”

Table_2_Hypermethylated GRIA4, a potential biomarker for an early non-invasive detection of metastasis of clinically known colorectal cancer.docx by Eva Lukacova (14727829)

“…</p>Methods<p>In total, 23 patients participated in this study, 7 patients with primary CRC and 16 patients with liver metastasis of clinically known CRC. We obtained tumor and non-tumor tissues (N=17), blood samples pre- and post-surgery (N=22), and blood of five volunteers without a personal cancer history. …”

Table_3_Hypermethylated GRIA4, a potential biomarker for an early non-invasive detection of metastasis of clinically known colorectal cancer.docx by Eva Lukacova (14727829)

“…</p>Methods<p>In total, 23 patients participated in this study, 7 patients with primary CRC and 16 patients with liver metastasis of clinically known CRC. We obtained tumor and non-tumor tissues (N=17), blood samples pre- and post-surgery (N=22), and blood of five volunteers without a personal cancer history. …”

Table_1_Hypermethylated GRIA4, a potential biomarker for an early non-invasive detection of metastasis of clinically known colorectal cancer.docx by Eva Lukacova (14727829)

“…</p>Methods<p>In total, 23 patients participated in this study, 7 patients with primary CRC and 16 patients with liver metastasis of clinically known CRC. We obtained tumor and non-tumor tissues (N=17), blood samples pre- and post-surgery (N=22), and blood of five volunteers without a personal cancer history. …”

Table_3_Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.docx by Yishan Liu (10808097)

“…However, the relationship between its dynamic changes and prognosis remains unclear.</p>Methods<p>We retrospectively enrolled 11,218 critically ill patients from a general and surgical intensive care unit (ICU) of a tertiary hospital between June 2016 and May 2020. …”

Image_4_Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.TIF by Yishan Liu (10808097)

“…However, the relationship between its dynamic changes and prognosis remains unclear.</p>Methods<p>We retrospectively enrolled 11,218 critically ill patients from a general and surgical intensive care unit (ICU) of a tertiary hospital between June 2016 and May 2020. …”

Table_1_Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.docx by Yishan Liu (10808097)

“…However, the relationship between its dynamic changes and prognosis remains unclear.</p>Methods<p>We retrospectively enrolled 11,218 critically ill patients from a general and surgical intensive care unit (ICU) of a tertiary hospital between June 2016 and May 2020. …”

Table_6_Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.docx by Yishan Liu (10808097)

“…However, the relationship between its dynamic changes and prognosis remains unclear.</p>Methods<p>We retrospectively enrolled 11,218 critically ill patients from a general and surgical intensive care unit (ICU) of a tertiary hospital between June 2016 and May 2020. …”

Image_1_Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.TIFF by Yishan Liu (10808097)

“…However, the relationship between its dynamic changes and prognosis remains unclear.</p>Methods<p>We retrospectively enrolled 11,218 critically ill patients from a general and surgical intensive care unit (ICU) of a tertiary hospital between June 2016 and May 2020. …”

Image_3_Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.TIFF by Yishan Liu (10808097)

“…However, the relationship between its dynamic changes and prognosis remains unclear.</p>Methods<p>We retrospectively enrolled 11,218 critically ill patients from a general and surgical intensive care unit (ICU) of a tertiary hospital between June 2016 and May 2020. …”

Table_2_Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.docx by Yishan Liu (10808097)

“…However, the relationship between its dynamic changes and prognosis remains unclear.</p>Methods<p>We retrospectively enrolled 11,218 critically ill patients from a general and surgical intensive care unit (ICU) of a tertiary hospital between June 2016 and May 2020. …”

Table_4_Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.docx by Yishan Liu (10808097)

“…However, the relationship between its dynamic changes and prognosis remains unclear.</p>Methods<p>We retrospectively enrolled 11,218 critically ill patients from a general and surgical intensive care unit (ICU) of a tertiary hospital between June 2016 and May 2020. …”

Image_2_Dynamic increase in myoglobin level is associated with poor prognosis in critically ill patients: a retrospective cohort study.TIFF by Yishan Liu (10808097)

“…However, the relationship between its dynamic changes and prognosis remains unclear.</p>Methods<p>We retrospectively enrolled 11,218 critically ill patients from a general and surgical intensive care unit (ICU) of a tertiary hospital between June 2016 and May 2020. …”

S3_all_filtered_occurrence_records.csv from The influence of scale-dependent geodiversity on species distribution models in a biodiversity hotspot by Beth E. Gerstner (17801016)

Table1_Influence of FMO3 and CYP3A4 Polymorphisms on the Pharmacokinetics of Teneligliptin in Humans.docx by Jin-Woo Park (624549)

Table3_Influence of FMO3 and CYP3A4 Polymorphisms on the Pharmacokinetics of Teneligliptin in Humans.docx by Jin-Woo Park (624549)